Related references
Note: Only part of the references are listed.Attenuation of cell motility observed with high doses of sphingosine 1-phosphate or phosphorylated FTY720 involves RGS2 through its interactions with the receptor S1P
Takayuki Kohno et al.
GENES TO CELLS (2008)
Effects of nimesulide, a cyclooxygenase-2 selective inhibitor, on colitis induced tumors
T. Inoue et al.
INFLAMMOPHARMACOLOGY (2008)
Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase
Lynn W. Maines et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions
Carolin Daniel et al.
MOLECULAR IMMUNOLOGY (2007)
Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate
Rajita Pappu et al.
SCIENCE (2007)
Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice
Barbara Zemann et al.
IMMUNOLOGY LETTERS (2007)
FTY720 ameliorates Th1-mediated colitis in mice by directly affecting the functional activity of CD4+CD25+ regulatory T cells
Carolin Daniel et al.
JOURNAL OF IMMUNOLOGY (2007)
Lysophospholipid receptors: Signalling, pharmacology and regulation by lysophospholipid metabolism
Dagmar Meyer zu Heringdorf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Sphingosine 1-phosphate as a novel immune regulator of dendritic cells
Angelo Martino
JOURNAL OF BIOSCIENCES (2007)
Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism
Chi Iou Lin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
被撤回的出版物: Sphingosine kinase 1 regulates pro-inflammatory responses triggered by TNFα in primary human monocytes (Retracted article. See vol. 227, pg. 2974, 2012)
Liang Zhi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology
Henrik von Wenckstern et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2006)
Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry
Jacek Bielawski et al.
METHODS (2006)
Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells
S Eigenbrod et al.
IMMUNOLOGICAL INVESTIGATIONS (2006)
Sphingosine kinase 1 is up-regulated in colon carcinogenesis
Toshihiko Kawamori et al.
FASEB JOURNAL (2006)
Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors - A novel pathway relevant to the pathophysiology of endothelium
C De Palma et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats
Ryoichi Tsubouchi et al.
DIGESTION (2006)
Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice
R Suzuki et al.
CARCINOGENESIS (2006)
Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells
S Sarkar et al.
FEBS LETTERS (2005)
Basal and induced sphingosine kinase 1 activity in A549 carcinoma cells:: function in cell survival and IL-1β and TNF-α induced production of inflammatory mediators
A Billich et al.
CELLULAR SIGNALLING (2005)
Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and α-actinin
PA Singleton et al.
FASEB JOURNAL (2005)
Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue
KR Johnson et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
Rheumatoid arthritis and anti-TNF-α therapy
C Gonzalez-Juanatey et al.
ATHEROSCLEROSIS (2005)
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands
H Kohno et al.
BMC CANCER (2005)
A critical role for sphingosine kinase in anaphylatoxin-induced neutropenia, peritonitis, and cytokine production in vivo
LP Vlasenko et al.
JOURNAL OF IMMUNOLOGY (2005)
The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice
AR Martín et al.
INFLAMMATION RESEARCH (2005)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720
ML Allende et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis
H Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Egress: a receptor-regulated step in lymphocyte trafficking
H Rosen et al.
IMMUNOLOGICAL REVIEWS (2003)
The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-α
BJ Pettus et al.
FASEB JOURNAL (2003)
Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester
NC Kaneider et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats
S Cuzzocrea et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)